机译:GcMAF:我们的下一代免疫疗法
Department of Life System, Institute of Technology and Science, Graduate School, The University of Tokushima, 2-1 Minamijosanjima-cho, Tokushima, Japan;
Department of Life System, Institute of Technology and Science, Graduate School, The University of Tokushima, 2-1 Minamijosanjima-cho, Tokushima, Japan;
Saisei Mirai Cell Processing Center, Nature21 Building 3F, 3-34-8 Okubo-cho,Moriguchi, Osaka, Japan;
Kobe Saisei Mirai Clinic, Kobe Commerce Industry and Trade Center Building 23F, 5-1-14, Hamabe-dori, Chuo-ku, Kobe, Japan;
Kobe Saisei Mirai Clinic, Kobe Commerce Industry and Trade Center Building 23F, 5-1-14, Hamabe-dori, Chuo-ku, Kobe, Japan, Division of Food and Drug Evaluation Science, Department of Community Medicine and Social Healthcare Science, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku,Kobe, Japan;
Inui Immunotherapy Clinic, 6-14-17 Kindacho, Moriguchi, Osaka, Japan;
Saisei Mirai Cell Processing Center, Nature21 Building 3F, 3-34-8 Okubo-cho,Moriguchi, Osaka, Japan, Kobe Saisei Mirai Clinic, Kobe Commerce Industry and Trade Center Building 23F, 5-1-14, Hamabe-dori, Chuo-ku, Kobe, Japan, Inui Immunotherapy Clinic, 6-14-17 Kindacho, Moriguchi, Osaka, Japan;
机译:撤回注释:用维生素D结合蛋白衍生的巨噬细胞激活因子GcMAF免疫治疗转移性结直肠癌[Cancer Immunology,Immunotherapy,57,(2008)1007-1016,DOI 10.1007 / s00262-007-0431-z]
机译:Yamamoto等人发表的出版物“用维生素D结合蛋白衍生的巨噬细胞激活的GcMAF免疫治疗转移性结直肠癌”的矛盾性和可疑性
机译:使用Gc蛋白衍生的巨噬细胞活化因子(GcMAF)的HIV感染患者的免疫疗法的撤回[J Med Virol,81(2009),16-26] DOI:10/1002 / jmv.21376。
机译:免疫疗法疫苗和过敏原:舌下免疫疗法的新证据
机译:与睡眠问题有关的癌症发病,死亡率和免疫疗法结果:心血管健康研究和癌症免疫治疗队列的结果
机译:Gc蛋白衍生的巨噬细胞活化因子GcMAF的前列腺癌免疫治疗
机译:Yamamoto等人发表的出版物“用维生素D结合蛋白衍生的巨噬细胞激活的GcMAF免疫治疗转移性结直肠癌”的矛盾性和可疑性